Quarterly report pursuant to Section 13 or 15(d)

Related Party Transactions (Details)

v3.8.0.1
Related Party Transactions (Details) - Memorial Sloan Kettering Cancer Center [Member]
3 Months Ended
Mar. 31, 2018
USD ($)
Receipt of regulatory approval from the U.S. FDA [Member]  
Summary of milestone payments related to related party  
Milestone payments $ 1,750,000
New Drug Application [Member]  
Summary of milestone payments related to related party  
Milestone payments $ 750,000